Financials

%ChgLast 12MReverse

	FY202312/31/2023	FY202412/31/2024	FY202512/31/2025	Last 12M06/30/2026
Cash and Cash Equivalents	6.0	1.7	8.5	3.2
Short Term Investments	-	-	-	-
Cash and Short Term Investments	6.0	1.7	8.5	3.2
Net Receivables	0.7	0.7	0.2	3.4
Inventory	-0.7	-	-	-
Other Current Assets	0.7	-	-	-
Total Current Assets	7.0	8.8	12.4	6.6
Property, Plant & Equipment	0.6	0.3	0.1	0.0
Long Term Investments	-	-	-	-
Other Non-Current Assets	-	-	-	-
Total Non-Current Assets	3.5	6.0	5.7	6.0
Total Assets	10.5	14.8	18.1	12.6
Account Payables	0.3	0.7	0.1	-
Short Term Debt	-	-	0.1	-
Deferred Revenue	-	1.5	0.6	-
Other Current Liabilities	4.2	0.9	3.4	2.8
Total Current Liabilities	5.6	5.0	6.1	2.8
Long Term Debt	-	-	-	-
Other Non-Current Liabilities	-	1.3	0.6	0.3
Total Non-Current Liabilities	0.3	1.4	0.6	0.3
Total Liabilities	5.9	6.5	6.8	3.1
Common Stock	1.2	6.7	14.1	14.2
Retained Earnings	-144.8	-150.4	-102.6	-104.0
Total Stockholders Equity	4.7	8.3	11.4	9.6
Total Liabilities and Equity	10.5	14.8	18.1	12.6

Biodexa Pharmaceuticals Plc American Depositary Receipt(BDRX US)